Vext Science, Inc. (CSE:VEXT)
 0.2800
 0.00 (0.00%)
  Oct 31, 2025, 2:37 PM EDT
Vext Science Revenue
Vext Science had revenue of $13.41M USD in the quarter ending June 30, 2025, with 59.10% growth. This brings the company's revenue in the last twelve months to $44.15M, up 32.45% year-over-year. In the year 2024, Vext Science had annual revenue of $36.00M with 3.40% growth.
Revenue (ttm) 
 $44.15M
Revenue Growth 
 +32.45%
P/S Ratio 
 1.15
Revenue / Employee 
 n/a
Employees 
 n/a
Market Cap 
69.35M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 36.00M | 1.19M | 3.40% | 
| Dec 31, 2023 | 34.81M | -598.33K | -1.69% | 
| Dec 31, 2022 | 35.41M | -1.83M | -4.92% | 
| Dec 31, 2021 | 37.24M | 12.05M | 47.83% | 
| Dec 31, 2020 | 25.19M | 2.87M | 12.86% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Curaleaf Holdings | 1.75B | 
| dentalcorp Holdings | 1.62B | 
| Trulieve Cannabis | 1.62B | 
| Green Thumb Industries | 1.57B | 
| Extendicare | 1.51B | 
| Verano Holdings | 1.16B | 
| WELL Health Technologies | 1.12B | 
| Sienna Senior Living | 929.68M |